Champions Oncology (CSBR) Other Non Operating Income (2010 - 2026)
Champions Oncology (CSBR) posted quarterly Other Non Operating Income of $27000.0 for Q2 2026, down 37.21% year-over-year from $43000.0 in Q2 2025, and down 30.77% quarter-over-quarter from $39000.0 in Q1 2026.
Champions Oncology (CSBR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Champions Oncology's Other Non Operating Income history runs 17 years deep, the most recent figure standing at $27000.0 for Q2 2026.
- In Q2 2026, Other Non Operating Income fell 37.21% year-over-year to $27000.0; the TTM figure through Apr 2026 stood at $211000.0 (up 185.14% YoY), while the FY2026 annual figure was $211000.0, up 189.04% from the prior year.
- Other Non Operating Income for Q2 2026 stood at $27000.0, down from $39000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $81000.0 in Q2 2024, with the low at -$105000.0 in Q4 2023.
- The 5-year median for Other Non Operating Income is $16500.0 (2023), against an average of $14166.7.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income sank 1066.67% in 2023, then jumped 1400.0% in 2025.
- Champions Oncology's Other Non Operating Income stood at -$9000.0 in 2022, then tumbled by 1066.67% to -$105000.0 in 2023, then jumped by 106.67% to $7000.0 in 2024, then surged by 900.0% to $70000.0 in 2025, then plunged by 61.43% to $27000.0 in 2026.
- Business Quant data shows CSBR's Other Non Operating Income at $27000.0 in Q2 2026, $39000.0 in Q1 2026, and $70000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 27,000.00 |
| Jan 31, 2026 | 39,000.00 |
| Oct 31, 2025 | 70,000.00 |
| Jul 31, 2025 | 75,000.00 |
| Apr 30, 2025 | 43,000.00 |
| Jan 31, 2025 | 19,000.00 |
| Oct 31, 2024 | 7,000.00 |
| Jul 31, 2024 | 5,000.00 |
| Apr 30, 2024 | 81,000.00 |
| Jan 31, 2024 | 58,000.00 |
| Oct 31, 2023 | -105,000.00 |
| Jul 31, 2023 | 14,000.00 |
| Apr 30, 2023 | -20,000.00 |
| Jan 31, 2023 | 36,000.00 |
| Oct 31, 2022 | -9,000.00 |
| Jul 31, 2022 | -18,000.00 |
| Apr 30, 2022 | -35,000.00 |
| Jan 31, 2022 | -32,000.00 |
| Oct 31, 2021 | 26,000.00 |
| Jul 31, 2021 | 17,000.00 |